Abnormalities in the proportions of CD4+ T lymphocyte subpopulations were detected more than two decades ago in SSc patients [17, 18], and since then, several studies proposed mechanistic alterations in these lymphocyte populations that may contribute to disease manifestations. The gene discussed is CD4; the disease is systemic sclerosis.